MedPath
HSA Approval

VALPARIN XR 500 TABLET 500 mg

SIN12559P

VALPARIN XR 500 TABLET 500 mg

VALPARIN XR 500 TABLET 500 mg

June 26, 2004

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N03AG01

valproic acid

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

TORRENT PHARMACEUTICALS LTD

Active Ingredients

VALPROIC ACID

145 mg

Valproic acid

SODIUM VALPROATE

333 mg

Valproic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VALPARIN XR 500 TABLET 500 mg - HSA Approval | MedPath